Semaglutide / Cyanocobalamin Injection ek combination therapy hai jo diabetes management aur nutritional deficiency dono ko address karne mein madad karti hai. Semaglutide blood sugar ko control karne mein sahayak hai, jabki Cyanocobalamin (Vitamin B12) energy metabolism, nerve function aur overall health ko support karta hai. Is injection ka use un logon mein kiya jata hai jinko type 2 diabetes ke saath Vitamin B12 ki kami bhi hoti hai, ya jinhe diet ya lifestyle ke karan nutritional support ki zarurat hai.

Semaglutide GLP-1 receptor agonist ke roop mein kaam karta hai, jo insulin secretion ko badhata hai aur glucose levels ko kam karne mein madad karta hai. Yeh digestion ko dheere kar deta hai, jisse khana dheere absorb hota hai aur blood sugar stable rehta hai. Cyanocobalamin body mein Vitamin B12 ki kami ko pura karta hai, jo red blood cells ke nirmaan, nervous system ke kaam, aur energy production mein zaruri hai. Dono milkar metabolic health ko behtar banate hain aur sharir ko sahi tarah se function karne mein madad karte hain.

Is injection ka use un logon mein saavdhani se karna chahiye jinhe kidney ya liver sambandhit bimari hai, ya jinhe hormone-related disorders hain. Agar aapko allergy, thyroid problems, ya blood disorders hain to doctor ko batana zaruri hai. Is dawa ko un logon mein use karne se bachna chahiye jo pehle se kisi active cancer ya uncontrolled diabetes se guzar rahe hain. Doctor ke supervision mein hi is injection ka regular use karna chahiye.

Aksar log ise achhi tarah tolerate kar lete hain, lekin kuch logon mein side effects ho sakte hain. Common lakshanon mein pet mein dard, ulti ya matli, muh ka sookhna, ya halki chakkar aana shamil hai. Vitamin B12 supplement ke karan kuch logon mein allergic reaction, skin rash, ya injection wali jagah par halka sujan bhi ho sakta hai. Agar kisi ko severe allergic pratikriya ya achanak asamanya lakshan dikhen to turant doctor se sampark karna chahiye.

Pregnancy ya breastfeeding ke dauran is injection ka upyog karne ko lekar paryapt clinical data uplabdh nahi hai. Agar kisi mahila ko diabetes ya Vitamin B12 deficiency ke chalte is injection ki zarurat ho to doctor ki salah zaruri hai.

Upon receipt of medication, immediately store between 35°F to 46°F (2°C – 8°C). Keep all medicines out of the reach of children. Throw away any unused medicine within 29 days of puncture or the BUD, which ever comes first. Do not flush unused medications or pour down a sink or drain.

1. Husain M, Birkenfeld AL, Donsmark M, et al. Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2019;381:841-851.
2. Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2018;41:26
3. Buse JB, Wexler DJ, Tsapas A, et al. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care
4. American Diabetes Association. Standards of Medical Care in Diabetes – 2022. Diabetes Care. 2022; 45(Suppl 1):S1-S270. Available at: https://diabetesjournals.org/care/issue/45/Supplement_1– LinkOpens in New Tab
5. Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus Statement by The American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm 2019 Executive Summary. End
6. Garvey WT, Mechanick JI, Brett EM, et al; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines.
7. Markle HV, Greenway DC. Cobalamin. Critical reviews in clinical laboratory sciences. 1996; 33: 247-356.
8. Herrmann W, Obeid R. Cobalamin deficiency. Subcell Biochem. 2012; 56: 301-322.
9. Paul C, Brady DM. Comparative Bioavailability and Utilization of Particular Forms of B12 Supplements With Potential to Mitigate B12-related Genetic Polymorphisms. Integrative Medicine: A Clinician’s Journal. 2017; 16: 42–49.
10. Vidal‐Alaball J, Butler C, Cannings‐John R, Goringe A, Hood K, McCaddon A, McDowell I, Papaioannou A. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database of Systematic Reviews. 2005: CD004655.
11. O’Leary F, Samman S. Vitamin B12 in health and disease. Nutrients. 2010; 2: 299-316.
12. Sweetman SC, editor. Martindale: the complete drug reference, 34th ed. London: Pharmaceutical press; 2014.
13. CaloMist™ Nasal Spray (cyanocobalamin, USP) label. 2007. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022102s000lbl.pdf– LinkOpens in New Tab [Accessed October 23, 2020].
14. Berry RJ. Lack of historical evidence to support folic acid exacerbation of the neuropathy caused by vitamin B12 deficiency. The American journal of clinical nutrition. 2019; 110: 554-61.
15. Russell -Jones D, Vaag A, Schmidtz O, et al. Liraglutide vs. insulin glargine and placebo in combination with metformin andsulphonylurea therapy in type 2 diabetes mellitus: a randomised controlled trial (LEAD-5 met + SU). Diabetologia 2009;52:20
16. Alamin A, Gupta V. Vitamin B12 (Cobalamin). In: StatPearls [Internet]. 2020. StatPearls Publishing.
17. Froese DS, Fowler B, Baumgartner MR. Vitamin B12, folate, and the methionine remethylation cycle—biochemistry, pathways, and regulation. Journal of inherited metabolic disease. 2019; 42: 673-685.
18. Berney M, Berney-Meyer L, Wong KW, Chen B, Chen M, Kim J, Wang J, Harris D, Parkhill J, Chan J, Wang F. Essential roles of methionine and S-adenosylmethionine in the autarkic lifestyle of Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences. 2015; 112: 10008-10013.
19. Vasavada A, Sanghavi D. Cyanocobalamin. In: StatPearls [Internet] 2020. StatPearls Publishing.
20. Sanz-Cuesta T, González-Escobar P, Riesgo-Fuertes R, Garrido-Elustondo S, del Cura-González I, Martín-Fernández J, Escortell-Mayor E, Rodríguez-Salvanés F, García-Solano M, González-González R, Martín-de la Sierra MÁ. Oral versus intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency: a pragmatic, randomised, multicentre, non-inferiority clinical trial undertaken in the primary healthcare setting (Project OB12). BMC Public Health. 2012; 12:1-1.
21. Food and Drug Administration (US FDA) Drug Medwatch-FDA investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes.
22. Everett J. Use of oral antidiabetic agents during breastfeeding. J Hum Lact 1997;13:319-21.
23. Hale TW, Kristensen JH, Hackett LP, et al. Transfer of metformin into human milk. Diabetologia 2002;45:1509-14.
24. Gardiner SJ, Kirkpatrick CMJ, Begg EJ, et al. Transfer of metformin into human milk. Clin Pharmacol Ther 2003;73:71-7.
25. Briggs GG, Ambrose PJ, Nageotte MP, et al. Excretion of metformin into breast milk and the effect on nursing infants. Obstet Gynecol 2005;105:1437-41.
26. American Academy of Pediatrics (AAP) Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001;108(3):776-789.
27. Feig DS, Donat DJ, Briggs GG, et al. Transfer of glyburide and glipizide into breast milk. Diabetes Care 2005;28:1851-5.
28. Spencer JP, Gonzalez LS, Barnhart DJ. Medications in the breastfeeding mother. Am Fam Physician 2001; 64:119-126.
29. Health Care Financing Administration. Interpretive Guidelines for Long-term Care Facilities. Title 42 CFR 483.25(l) F329: Unnecessary Drugs. Revised 2015.
30. Caballero MR, Lukawska J, Lee TH, Dugué P. Allergy to vitamin B12: two cases of successful desensitization with cyanocobalamin. Allergy. 2007; 62: 1341-1342.
31. CYANOCOBALAMIN INJECTION, USP 1000 mcg/mL Sterile (Vitamin B12) [Label]. 2014. Available from: https://pdf.hres.ca/dpd_pm/00026115.PDF– LinkOpens in New Tab [Accessed October 26, 2020].
32. CYANOCOBALAMIN- cyanocobalamin injection, USP. West-Ward Pharmaceuticals Corp [Label]. 2018. Available from: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=a66eb3c4-3e1d-4d49-b963-4fa2334cc9b6– LinkOpens in New Tab [Accessed October 26, 2020].
33. Nascobal® (Cyanocobalamin, USP) Nasal Spray 500 mcg/spray 0.125 mL [Label]. 2014. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021642s020lbl.pdf– LinkOpens in New Tab [Accessed October 26, 2020].
34. Carmel R. How I treat cobalamin (vitamin B12) deficiency. Blood. 2008; 112: 2214-2221.
35. Solomon LR. Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment. Blood reviews. 2007; 21: 113-130.
36. Chandyo RK, Ulak M, Kvestad I, Shrestha M, Ranjitkar S, Basnet S, Hysing M, Shrestha L, Strand TA. The effects of vitamin B12 supplementation in pregnancy and postpartum on growth and neurodevelopment in early childhood: Study Protocol for a Randomized Placebo Controlled Trial. BMJ open. 2017; 7: e016434.
37. Samson RR, McClelland DB. Vitamin B12 in human colostrum and milk: quantitation of the vitamin and its binder and the uptake of bound vitamin B12 by intestinal bacteria. Acta Pædiatrica. 1980; 69: 93-99.
38. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001; 10